Literature DB >> 16828171

Recovery of human papillomavirus nucleic acids from liquid-based cytology media.

Ned Powell1, Kelly Smith, Alison Fiander.   

Abstract

Residual material from liquid-based cytology (LBC) samples, collected during cervical screening, is a valuable resource for molecular biological analysis. Because of the central role played by human papillomavirus (HPV) in the development of cervical cancer, assays are being developed to quantify HPV gene expression in LBC material. Using quantitative realtime PCR we have compared recovery of HPV DNA and RNA from two of the most widely used LBC systems (the ThinPrep system (Cytyc Corp.) and the SurePath system (TriPath Imaging, Inc.)). Recovery of RNA was unaffected by storage in ThinPrep media, however storage of cells in SurePath resulted in significantly reduced yields (between 10(4)- and 10(8)-fold reduction depending on extraction technique). Given the increasing prominence and importance of molecular diagnostics and prognostics this is an important finding, and must be considered in relation to choice of LBC system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828171     DOI: 10.1016/j.jviromet.2006.05.033

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  14 in total

1.  Long-term stability of human genomic and human papillomavirus DNA stored in BD SurePath and Hologic PreservCyt liquid-based cytology media.

Authors:  Patricia M Agreda; Gerard H Beitman; Erin C Gutierrez; James M Harris; Kristopher R Koch; William D LaViers; Sharon V Leitch; Courtney E Maus; Ray A McMillian; William A Nussbaumer; Marcus L R Palmer; Michael J Porter; Gregory A Richart; Ryan J Schwab; Laurence M Vaughan
Journal:  J Clin Microbiol       Date:  2013-05-15       Impact factor: 5.948

2.  mRNA biomarker detection in liquid-based cytology: a new approach in the prevention of cervical cancer.

Authors:  Marta Del Pino; Cecilia Svanholm-Barrie; Aureli Torné; Lorena Marimon; Jina Gaber; Amaia Sagasta; David H Persing; Jaume Ordi
Journal:  Mod Pathol       Date:  2014-09-05       Impact factor: 7.842

3.  Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification.

Authors:  Gaëlle A V Boulet; Isabel M Micalessi; Caroline A J Horvath; Ina H Benoy; Christophe E Depuydt; Johannes J Bogers
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

4.  Diverse mechanisms of growth inhibition by luteolin, resveratrol, and quercetin in MIA PaCa-2 cells: a comparative glucose tracer study with the fatty acid synthase inhibitor C75.

Authors:  Diane M Harris; Luyi Li; Monica Chen; F Tracy Lagunero; Vay Liang W Go; Laszlo G Boros
Journal:  Metabolomics       Date:  2011-03-25       Impact factor: 4.290

5.  APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database.

Authors:  Samer N Khader; Kathie Schlesinger; Josh Grossman; Richard I Henry; Mark Suhrland; Amy S Fox
Journal:  Cytojournal       Date:  2010-07-02       Impact factor: 2.091

Review 6.  Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.

Authors:  Kate Cuschieri; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

7.  Ease and comfort of cervical and vaginal sampling for Chlamydia trachomatis and Trichomonas vaginalis with a new Aptima specimen collection and transportation kit.

Authors:  Max Chernesky; Dan Jang; Jodi Gilchrist; Joan Randazzo; Laurie Elit; Alice Lytwyn; Marek Smieja; Jennifer Reid; Craig Hill
Journal:  J Clin Microbiol       Date:  2013-12-04       Impact factor: 5.948

8.  Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests.

Authors:  Keith D Tardif; Michael T Pyne; Elisabeth Malmberg; Tatum C Lunt; Robert Schlaberg
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

9.  Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-C(6)]-d-glucose tracer in mice.

Authors:  Richard D Beger; Deborah K Hansen; Laura K Schnackenberg; Brandie M Cross; Javad J Fatollahi; F Tracy Lagunero; Zoltan Sarnyai; Laszlo G Boros
Journal:  Metabolomics       Date:  2009-03-31       Impact factor: 4.290

10.  Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening.

Authors:  Sonya Naryshkin; R Marshall Austin
Journal:  Drug Healthc Patient Saf       Date:  2012-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.